Analyst Ratings for Cabaletta Bio
Portfolio Pulse from Benzinga Insights
In the last quarter, Cabaletta Bio (NASDAQ:CABA) received 4 bullish ratings from analysts. The company has an average 12-month price target of $26.75, with a high of $34.00 and a low of $17.00. The average price target has increased by 78.33% over the past month.
September 05, 2023 | 12:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cabaletta Bio received 4 bullish ratings from analysts in the last quarter, with an average 12-month price target of $26.75.
The bullish ratings and the increase in the average price target over the past month indicate a positive sentiment among analysts towards Cabaletta Bio. This could potentially lead to an increase in the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100